Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Virus-like particles(VLPs) are formed by self-assembly of envelop/capsid proteins from viruses. Membrane Proteins can be constituted in-situ with VLPs produced from HEK293 cell cultures. These VLPs concentrate conformationally intact membrane proteins directly on the cell surface and produce soluble, high-concentration proteins perfect for immunization and antibody screening.
The VLPs provide the display of properly folded membrane proteins in their native cellular membrane in a compact size of 100~300 nm diameter (similar to the size of most viruses) making it optimal targets for dendritic cells in vivo and surface attachment for phage display.
The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).
Supplied as 0.2 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
This product is supplied and shipped with dry ice, please inquire the shipping cost.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
Immobilized Human ADORA2A Full Length Protein-VLP (Cat. No. ADA-H52P4) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-Human ADORA2A antibody, Human IgG1 with a linear range of 0.3-5 ng/mL (QC tested).
The mean peak Radius of VLP is 55-70 nm with more than 95% intensity as determined by dynamic light scattering (DLS).
Price(USD) : $620.00
Price(USD) : $1235.00
Price(USD) : $4305.00
Explore our catalog of therapeutic antibody solutions to find the right products for you! We are dedicated to delivering solutions designed to help you drive innovation and push the boundaries of what therapeutic antibodies can be.
We offer a wide range of cell and gene therapy solutions starting from discovery to the clinic. Explore our wide range of proteins, antibodies, kits, and other assays to accelerate the development of your cell and gene therapy.
Organoid Toolbox is a collection of organoid solutions including ready-to-use organoids, organoid differentiation kits, and a variety of services to accelerate the progress of your drug development project.
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2, CD133, GPRC5D,CCR8, CCR5, etc.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
Comprehensive cytokine targets including interleukins, growth factors, chemokines, TNFs, etc. are expressed by HEK293 to ensure their natural structure. Their high purity is verified by SDS-PAGE/HPLC/SEC-MALS and high bioactivity is verified by ELISA/SPR/BLI.
Aneuro provides comprehensive tools for neuroscience research, including neuroscience proteins, pre-formed fibrils (PFFs), neural antibodies, neural factors, and more—aiming to accelerate disease modeling, drug screening, and neural mechanism studies.
English Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Regadenoson Hydrate | CVT-3146 | Approved | Astellas Pharma Inc | Lexiscan, Rapiscan | United States | Contrast agents | Astellas Pharma Inc | 2008-04-10 | Myocardial Ischemia; Rejection of lung transplantation; Cardiovascular contrast agents; Pneumonia; Glioblastoma; Coronary Artery Disease; Retinal Artery Occlusion; Heart Diseases; Coronavirus Disease 2019 (COVID-19); Oligodendroglioma; Contrast agents; Astrocytoma; Cardiovascular Diseases; Glioma; Diagnostic agents; Anemia, Sickle Cell | Details |
Caffeine/Ergotamine Tartrate | Approved | Novartis Pharma Ag | Cafergot | Mainland China | Migraine Disorders | Tianjin Medical University Pharmaceutical Factory | 1948-11-26 | Migraine Disorders | Details | |
Oxtriphylline | Approved | Theocolin | Canada | null | Asthma | Details | ||||
Caffeine/Metamizole Sodium/Dihydroergotamine Mesylate | Approved | Cefaliv | Migraine Disorders | Details | ||||||
Adenine | Approved | Leucon | Japan | Leukopenia | Ohara Pharmaceutical Co Ltd | Leukemia; Leukopenia | Details | |||
Acetaminophen/Butalbital/Caffeine/Codeine Phosphate | Approved | Actavis Laboratories Ut Inc | United States | Headache; Headache Disorders | Actavis Laboratories Ut Inc | 1992-07-30 | Headache; Headache Disorders | Details | ||
Istradefylline | KW-6002 | Approved | Kyowa Hakko Kirin Co Ltd | Nourianz, Nouriast | Japan | Parkinson Disease | Kyowa Hakko Kirin Co Ltd | 2013-03-25 | Substance-Related Disorders; Restless Legs Syndrome; Sleep Wake Disorders; Parkinson Disease; Hepatic Insufficiency; Movement Disorders; Cognition Disorders; Amyotrophic Lateral Sclerosis | Details |
Acetaminophen/Methylephedrine Hydrochloride/Dextromethorphan Hydrobromide/Chlorphenamine Maleate/Caffeine/Sulfogaiacol | Approved | Mainland China | Common Cold | Zhejiang Apeloa Kangyu Pharmaceutical Co Ltd | Common Cold | Details | ||||
Dextromethorphan Hydrobromide/Chlorphenamine Maleate/Sodium Citrate/Ammonium Chloride/Caffeine | Approved | 尔可芬 | Cough | Details | ||||||
Acetaminophen/Caffeine/Codeine Phosphate/Diphenhydramine Hydrochloride | Approved | 斯力帮 | Headache | Details | ||||||
Ferric Ammonium Citrate/Vitamin B1/Sodium glycerophosphate/Caffeine | Approved | Ischemia | Details | |||||||
Norethidranum Dipropionas/Caffeine/Vitamin B6 | Approved | Mainland China | Contraception | Huazhong Pharmaceutical Co Ltd | 1981-01-01 | Contraception | Details | |||
Acetaminophen/Propyphenazone/Caffeine | Approved | 散利痛, 散列通 | Common Cold | Details | ||||||
Quinine Hydrochloride Hydrate/Caffeine | Approved | Malaria | Details | |||||||
Dihydroergocryptine/Caffeine | Approved | 洛斯宝, VASOBRAL | Diabetic Retinopathy; Diabetes Mellitus | Details | ||||||
Aminophenazone/Phenacetin/Caffeine | Approved | Pain; Fever | Details | |||||||
Aminophenazone/Caffeine/Calcium Glycerophosphate | Approved | Headache; Dysmenorrhea; Neuralgia | Details | |||||||
Acetaminophen/Caffeine/Chlorphenamine Maleate | Approved | Common Cold | Details | |||||||
Aminophenazone/Caffeine/Chlorphenamine Maleate | Approved | Headache; Common Cold; Neuralgia | Details | |||||||
Aspirin/Caffeine/Codeine Phosphate | Approved | 柯克 | Pain | Details | ||||||
Acetaminophen/Pseudoephedrine Hydrochloride/Caffeine | Approved | Common Cold | Details | |||||||
Aspirin/Acetaminophen/Caffeine/Chlorphenamine Maleate | Approved | Common Cold | Details | |||||||
Aspirin/Caffeine/Chlorphenamine Maleate/Tartaric Acid | Approved | Common Cold | Details | |||||||
Acetaminophen/Caffeine/Pseudoephedrine Hydrochloride/Chlorphenamine Maleate | Approved | Common Cold | Details | |||||||
Aminophenazone/Phenacetin/Caffeine/Phenobarbital | Approved | Migraine Disorders | Details | |||||||
Acetaminophen/Chlorphenamine Maleate/Caffeine/Guaifenesin | Approved | Common Cold | Details | |||||||
Acetaminophen/Amantadine Hydrochloride/Caffeine/Artificial Bezoar | Approved | Common Cold | Details | |||||||
Acetaminophen/Salicylamide/Pseudoephedrine Hydrochloride/Caffeine/Triprolidine Hydrochloride Hydrate | Approved | 联邦菲迪乐 | Common Cold | Details | ||||||
Sodium Benzoate/Caffeine | Approved | Central Nervous System Diseases | Details | |||||||
Aminophenazone/Caffeine | Approved | Fever | Details | |||||||
Antipyrine/Caffeine | Approved | Common Cold | Details | |||||||
Aspirin/Caffeine | Approved | Common Cold | Details | |||||||
Antipyrine/Caffeine/Citric Acid | Approved | 米格来宁 | Mainland China | Sedation | Mudanjiang Lingtai Medicdment Co Ltd, Xi'An Disai Biological Pharmaceutical Co Ltd, Heilongjiang Hasing Pharmaceutical Group Co Ltd, Huadong Medicine (Xi'An) Bodyguard Pharmaceutical Co Ltd | 1982-01-01 | Sedation | Details | ||
Aminophenazone/Acetaminophen/Caffeine/Chlorphenamine Maleate | Approved | 克感敏, 扑感敏, 朴感敏 | Common Cold | Details | ||||||
Acetaminophen/Caffeine/Ephedrine Hydrochloride/Diphenhydramine Hydrochloride | Approved | Influenza, Human | Details | |||||||
Acetaminophen/Caffeine/Chlorphenamine Maleate/Artificial Bezoar | Approved | Common Cold | Details | |||||||
Aspirin/Phenacetin/Caffeine | Approved | Headache; Dysmenorrhea; Toothache; Fever; Neuralgia; Arthralgia | Details | |||||||
Aspirin/Caffeine/Acetaminophen | Approved | United States | Migraine Disorders | Haleon PLC | Migraine Disorders; Anesthesia | Details | ||||
Acetaminophen/Butalbital/Caffeine | Approved | Headache | Details | |||||||
Acetaminophen/Caffeine | Approved | Zentiva As | Mainland China | Pain | Sino--American Shanghai Squibb Pharmaceutical Ltd | Pain | Details | |||
Sodium glycerophosphate/Caffeine/Vitamin B/Phosphoric Acid/Niacin | Approved | Details | ||||||||
Acetaminophen/Caffeine/Phenylephrine Hydrochloride/Chlorphenamine Maleate/Vitamin B | Approved | Details | ||||||||
Acetaminophen/Chlorphenamine Maleate/Methylephedrine Hydrochloride/Sulfogaiacol/Caffeine | Approved | Mainland China | Common Cold | Hainan Sanfengyou Pharmaceutical Co Ltd | 2006-05-16 | Common Cold | Details | |||
Brompheniramine Maleate/Bromhexine Hydrochloride/Caffeine/Acetaminophen/Phenylephrine Hydrochloride | Approved | Common Cold | Details | |||||||
Acetaminophen/Amantadine Hydrochloride/Caffeine/Chlorphenamine Maleate/Artificial Bezoar | Approved | 复方氨酚烷胺 | Mainland China | Common Cold | null | 1984-01-01 | Common Cold | Details | ||
Caffeine | Approved | Fatigue; Memory Disorders; Mental Fatigue; Sexual Dysfunction, Physiological; Cocaine-Related Disorders; Cognitive Dysfunction; Diabetic Nephropathies; Diabetes Complications; Parkinson Disease; Postoperative Cognitive Complications; Diabetes Mellitus, Type 1; Delirium; Apnea; Disorders of Excessive Somnolence; Intermittent Claudication; Spinal Cord Injuries; Fetal Membranes, Premature Rupture; Consciousness; Sleepiness | Details |
English Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Naproxen/Caffeine | BAY-2880376 | Phase 3 Clinical | Bayer AG | Pain, Postoperative | Details |
Caffeinol | Phase 3 Clinical | Cardium Therapeutics | Alcoholic Intoxication; Ischemic Stroke; Alcoholism; Disruptive, Impulse Control, and Conduct Disorders; Carcinoma, Non-Small-Cell Lung | Details | |
Imaradenant | AZD-4635; HTL-1071 | Phase 2 Clinical | Nxera Pharma UK Ltd | Solid tumours; Prostatic Neoplasms, Castration-Resistant | Details |
Ciforadenant | CPI-444; V-81444 | Phase 2 Clinical | Vernalis (R&D) Ltd | Carcinoma, Renal Cell; Neoplasms; Attention Deficit Disorder with Hyperactivity; Multiple Myeloma; Parkinson Disease; Carcinoma, Non-Small-Cell Lung | Details |
Etrumadenant | AB-928; GS-0928 | Phase 2 Clinical | Arcus Biosciences Inc | Prostatic Neoplasms; Melanoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Laryngeal Neoplasms; Mouth Neoplasms; Pharyngeal Neoplasms; Carcinoma, Squamous Cell; Endometrial Neoplasms; Carcinoma, Pancreatic Ductal; Lung Neoplasms; Colorectal Neoplasms; Oropharyngeal Neoplasms; Breast Neoplasms; Head and Neck Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms, Castration-Resistant; Triple Negative Breast Neoplasms; Hypopharyngeal Neoplasms; Carcinoma, Transitional Cell; Hormone-Resistant Prostate Neoplasms; Esophageal Neoplasms; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Ovarian Neoplasms | Details |
KW-6356 | KW-6356 | Phase 2 Clinical | Kyowa Hakko Kirin Co Ltd | Parkinson Disease; Hepatic Insufficiency | Details |
PORT-8 | PORT-8; TT-53 | Phase 2 Clinical | Tarus Therapeutics Inc | Solid tumours | Details |
PORT-6 | PORT-6; TT-10 | Phase 2 Clinical | Impetis Biosciences Ltd | Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Prostatic Neoplasms, Castration-Resistant; Carcinoma, Non-Small-Cell Lung | Details |
MK-1088 | MK-1088 | Phase 2 Clinical | Merck Sharp & Dohme LLC | Solid tumours | Details |
VG081821AC | VG-081821AC; VG081821AC | Phase 2 Clinical | Zhejiang Vimgreen Pharmaceuticals Ltd | Parkinson Disease | Details |
ILB-2109 | WTS-001; ILB-2109 | Phase 2 Clinical | Hangzhou Wutong Tree Pharmaceutical Co Ltd | Solid tumours; Ovarian Neoplasms; Head and Neck Neoplasms; Neoplasms; Hodgkin Disease; Triple Negative Breast Neoplasms; Sarcoma; Nasopharyngeal Carcinoma; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma | Details |
PBF-999 | PBF-999 | Phase 1 Clinical | Palobiofarma Sl | Neoplasms; Huntington Disease | Details |
SHR-5126 | SHR-5126 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd | Neoplasms | Details |
Taminadenant | NIR-178; PBF-509 | Phase 1 Clinical | Palobiofarma Sl | Head and Neck Neoplasms; Solid tumours; Ovarian Neoplasms; Carcinoma, Renal Cell; Carcinoma; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Prostatic Neoplasms, Castration-Resistant; Colorectal Neoplasms; Parkinson Disease; Carcinoma, Pancreatic Ductal; Melanoma; Carcinoma, Non-Small-Cell Lung | Details |
ST-4206 | ST-4206 | Phase 1 Clinical | Alfasigma Spa | Parkinson Disease | Details |
JNJ-86974680 | JNJ-86974680 | Phase 1 Clinical | Johnson & Johnson Enterprise Innovation Inc | Carcinoma, Non-Small-Cell Lung | Details |
YZJ-5053 | YZJ5053; YZJ-5053 | Phase 1 Clinical | Shanghai Haiyan Pharmaceutical Technology Co Ltd | Solid tumours; Neoplasm Metastasis | Details |
CT-1500 | CT-1500 | Phase 1 Clinical | Circadian Technologies Ltd | Details | |
EXS-21546 | EXS-21546; EVOEXS21546 | Phase 1 Clinical | Exscientia Ltd | Solid tumours; Neoplasms | Details |
DZD-2269 | Phase 1 Clinical | Dizal Pharmaceutical Co Ltd | Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details | |
INCB-106385 | INCB-106385 | Phase 1 Clinical | Incyte Corp | Ovarian Neoplasms; Solid tumours; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Prostatic Neoplasms, Castration-Resistant; Urinary Bladder Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
CS-3005 | CS-3005 | Phase 1 Clinical | Cstone Pharmaceuticals (Suzhou) Co Ltd | Solid tumours | Details |
Sodium Citrate/Citric Acid/Dextrose/Monosodium phosphate/Adenine/Mannitol/Sodium Chloride | Details | ||||
Sodium Citrate/Citric Acid/Dextrose | Details | ||||
Sodium Citrate/Citric Acid/Dextrose/Monosodium phosphate/Adenine | Details | ||||
Aspirin/Acetaminophen/Caffeine/Thiamine | Details | ||||
Propranolol hydrochloride/Caffeine/Phenytoin Sodium | Details | ||||
Ethenzamide/Caffeine/Chlorzoxazone | Details | ||||
Salicylamide/Acetaminophen/Caffeine | Details |
This web search service is supported by Google Inc.